ASCO GU 2017: Informed decision making (IDM) for prostate cancer (PCa) screening in a high-risk population. - Session Highlights
An educational powerpoint highlighting components of the IDS was given to 116 patients along with a 15-question pre and post- test. It was a high risk group with over 90% being african american, 21% had a family history. The intervention increased the number of correct answers regarding screening. 82% pts favored the education process before screening and 75% of all pts found the information “very helpful” in decision-making.
The authors were able to conclude that education-based informed decision improved patient knowledge about prostate cancer and most preferred the education process. This is approach is an applicable and feasible and appears feasible. We commend their work easing the burdeen of the decision for screening off of the patient and the primary care physician.
Author: Puneet Dhillon
Written By: Michael J Metcalfe, MD, Fellow of Urologic Oncology Urology, MD Anderson Cancer Center, Houston TX
Ashish M. Kamat, MD, MBBS, FACS, President, International Bladder Cancer Network Chair, Society of Immunotherapy for Cancer (SITC), BCTF, Director of Urologic Oncology Fellowship, Professor of Urology, Attending Surgeon, Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston TX
at the 2017 Genitourinary Cancers Symposium - February 16 - 18, 2017 – Orlando, Florida USA